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Speech Sound Disorder and Visual
Biofeedback Intervention: A Preliminary
Investigation of Treatment Intensity
Elaine R. Hitchcock, Ph.D., CCC-SLP,1
Michelle T. Swartz, M.A., CCC-SLP,1 and Melissa Lopez, M.A., CFY-SLP1

A growing body of research suggests that cases of speech sound
errors that have not responded to previous intervention can sometimes be
eliminated through speech therapy incorporating visual biofeedback.
Aside from considerations related to the specific biofeedback type,
acquisition and generalization of a motor plan may be linked to treatment
intensity. Several researchers have raised the possibility that inadequate
dosage levels may present a significant barrier to success. Thus, the
current study aimed to assess the relationship between treatment intensity
and treatment outcomes. Twenty-nine articles reporting the use of visual
biofeedback intervention for speech sound disorder were identified and
coded for treatment intensity using the cumulative intervention index and
outcomes using mean level difference scores. Findings reveal small but
significant relationships between measures of treatment intensity and
efficacy, which should be interpreted with caution given the preliminary
nature of this review. Further research in this area is necessary, as
inconsistencies in reporting intensity and outcomes across studies underscore the need for more systematic terminology and reporting methods.
KEYWORDS: residual speech errors, childhood apraxia of speech,
treatment intensity, dose, visual biofeedback
Learning Outcomes: As a result of this activity, the reader will be able to (1) identify three major types of
visual biofeedback used as a method of treatment for speech sound errors and identify reasons for the
variable nature of treatment outcomes; (2) define formal definitions for measuring treatment intensity
including dose, dose frequency, and total intervention duration; (3) describe the challenges associated with
measuring treatment intensity and efficacy for treatment of speech sound errors.
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ABSTRACT

A growing body of research indicates that

visual biofeedback techniques may be efficacious
in treating speech sound disorder (SSD). However, across biofeedback studies, individual treatment response ranges from no measurable
difference to complete generalization of target
productions at the level of conversational
speech.1–7 Such outcomes raise questions about
why treatment gains generalize for some, but not
all, participants. Aside from individual differences (e.g., attention, motivation), relevant factors
related to treatment planning may include the
type of visual biofeedback, complexity of treatment targets, practice schedule, feedback type
(e.g., knowledge of performance vs. knowledge of
results), schedule of feedback, and treatment
intensity (i.e., frequency, duration). Several
researchers have begun to compare biofeedback
versus non-biofeedback conditions8,9 as well as
the impact of practice and feedback,10 yet presently, none of these findings have definitively
revealed a favored treatment, method of practice,
or feedback condition. Treatment intensity, however, has been gaining widespread attention as a
significant factor in SSD research, particularly for
disorders associated with motor speech skills.11,12
Yet despite the growing focus on treatment
intensity for traditional SSD intervention programs, little biofeedback research has directly
addressed its importance for the successful acquisition and generalization of new speech skills.

VISUAL BIOFEEDBACK
TECHNIQUES
Recent technological advances have the potential
to revolutionize the clinical management of
children with SSD. Many studies have focused
on alternative treatments, specifically visual biofeedback intervention, for a subset of individuals
whose errors persist despite intervention. This
subset includes children with motor speech difficulties such as residual speech errors (RSE) and
childhood apraxia of speech (CAS). Both populations include individuals whose errors often do
not remediate with traditional speech therapy
methods. Throughout the article, we will refer to
these errors as “residual” errors, a general term in
which we are including the category of “persistent” errors. Such errors may continue even in
children who have undergone extensive periods

of intervention.13,14 When not remediated, the
presence of speech sound errors may negatively
impact a child’s overall social, emotional, and
academic well-being.15,16
Traditionally, learners are taught to alter
inaccurate speech sounds through auditory feedback instruction. The introduction of biofeedback allows learners to use a visual modality to
identify aspects of speech that are challenging for
them to distinguish under typical circumstances.17 Specifically, the use of visual biofeedback
provides a real-time visual representation of the
user’s speech which can be compared against a
model representing correct production of a target sound. The external representation of an
accurate speech target facilitates correction of an
error pattern instead of relying on internal selfperception. These effects have been documented
across various biofeedback technologies, including acoustic biofeedback, in which the client
views a computer-generated acoustic representation (e.g., LPC spectrum5,18 or spectrogram1)
of his/her speech; ultrasound biofeedback,7,19 in
which an ultrasound probe held beneath the chin
generates an image of the client’s tongue during
speech; electropalatography,20,21 which uses a
pseudopalate to register and display areas of
contact between the client’s tongue and palate;
and electromagnetic articulography, in which an
animated 3D tongue avatar moves in real time
with the client’s own tongue.22,23
The benefit of incorporating visual biofeedback as a dynamic, visual teaching modality
is rapidly gaining recognition in the field of
speech–language pathology. Several small-scale
studies have found that visual biofeedback
treatment can be successful in eliminating
speech sound errors. However, variations in
treatment response may be, in part, secondary
to differences in treatment intensity.

VISUAL BIOFEEDBACK AND
TREATMENT INTENSITY
According to Warren et al,24 treatment intensity
may be an essential variable in optimizing the
effectiveness of intervention in the field of communication disorders. This premise is not surprising given that intervention intensity is one of
the well-cited principles of rehabilitation. The
intensity of a training task, aimed at the

125

Downloaded by: Montclair State University. Copyrighted material.

VISUAL BIOFEEDBACK AND TREATMENT INTENSITY/HITCHCOCK ET AL

SEMINARS IN SPEECH AND LANGUAGE/VOLUME 40, NUMBER 2

improvement of a specific skill such as production
of a speech sound, can affect neural connectivity25
and serve to document intensity as a necessary
element for achieving optimal progress in speech
intervention. As noted previously, little biofeedback research has directly addressed the importance of treatment intensity for the successful
acquisition and generalization of motor learning.
Findings by Preston and colleagues26 suggest that
the impact of treatment intensity may be maximized during specific phases of treatment. For
example, high intensity levels may be more
valuable when the individual is learning a new
motor plan compared with later, in the generalization phase. In a case series study composed of
four participants presenting with residual rhotic
errors that had not resolved with previous therapy, a high-frequency intervention program
composed of twice daily sessions for a period of
1 week resulted in significant gains for all participants. Thus, clinicians might improve client
outcomes by initially providing an intense frequency intervention schedule, ideally greater than
the typical model of one to two sessions per week.
Perhaps because the field has yet to definitively adopt a standard for reporting treatment
intensity variables, methodological descriptions
vary widely across treatment studies’ with most
studies reporting some combination of the following treatment measures: (1) overall duration,
(2) total number of sessions, (3) number of
sessions per week, (4) length of treatment session, (5) session length in minutes, and (6)
number of teaching episodes per session. Relatively few studies report and/or define these
variables in the exact same fashion, making valid
comparisons of study outcomes challenging.

Using the Cumulative Intervention
Index to Evaluate Treatment Intensity
Warren et al24 reviewed the existing literature
relative to dosage in communication and language development, concluding that “treatment
intensity research is of utmost importance in
developing optimally efficacious interventions.”24 They noted that there was surprisingly
little literature in communication disorders
designed to specifically evaluate the impact of
treatment intensity. They proposed formal definitions for measuring treatment intensity inclu-
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ding dose (number of teaching episodes per
session), dose frequency (number of treatment
sessions per week), and total intervention duration
(total time period of intervention) and developed
the cumulative intervention index (CII). The CII
is calculated by multiplying these dosage variables to generate a single numerical measure
intended to aid in the investigation of treatment
efficacy. Standardization of dosage parameters
provides a framework well suited for comparing
treatment outcomes on the basis of intensity.
Furthermore, analysis of treatment intensity
provides a structure for examining the range of
treatment responses reported for participants
using visual biofeedback. Some researchers,
such as Preston and colleagues, have investigated
the effects of high-intensity ultrasound biofeedback treatment for RSE and speech errors in
childhood apraxia,26,27 but these effects have not
yet been compared with other biofeedback techniques using one unified outcome measure.
Given evidence of both strong responders and
nonresponders to biofeedback treatment,1–4
exploring the role of treatment intensity may
help identify dosage factors that align with
positive participant treatment outcomes.9

Article Review
The purpose of the current study was to review
the existing literature on biofeedback for treatment of speech sound errors using the CII as a
measure of comparison for treatment intensity.
The aim of this analysis was not to propose a
singular cause–effect relationship between
treatment intensity and efficacy, as it is clear
that other variables such as treatment type,
practice conditions, and feedback methods
may impact treatment success. Instead, the
aim of this paper was to explore the relationship
between treatment intensity and treatment outcomes. Outcomes associated with dose parameters have the potential to influence future
visual biofeedback intervention programs.

METHOD
Search Strategy
A computer-based search was undertaken
to identify papers investigating the use of
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diagram depicting the study selection process is
presented in Fig. 1.
Search terms. Ten databases related to
health sciences were comprehensively searched
via Montclair State University’s library portal
for peer-reviewed journal articles. For a detailed
list of databases and search terms, see Table 1.
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biofeedback for treatment of SSDs from January 1980 to July 2018. The search strategy
followed the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses
(PRISMA) search guidelines.28 All available
databases related to health sciences were selected for inclusion in the present review. The flow
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Figure 1 Flow diagram of study selection (adapted from Preferred Reporting Items for Systematic Reviews
and Meta-Analyses [PRISMA]).28 RCT, randomized controlled trial; SCED, single-case experimental design;
RSE, residual speech error; CAS, childhood apraxia of speech.
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Table 1 Databases
Systematic Review

and

Terms

used

in

Databases
searched

Search terms

Social Sciences

“biofeedback,” “ultrasound,”

Citation Index
Science Citation

electropalatography,”
or “visual acoustic”

Index

and

Academic Search
Complete

“speech sound disorder,”
“speech sound disorders,”

Education Research

“phonological intervention,”

Complete
CINAHL Complete

“residual speech errors,”
“articulation impairments,”

PsycINFO

“speech impairments,”

ERIC
ScienceDirect

“speech therapy,”
or “speech”

SciELO
British Library EthOS

Screening. Articles were exported to EndNote X7,29 where duplicates were removed,
resulting in 477 studies. An initial screening
of the 477 studies revealed a diverse set of
etiological factors associated with a diagnosis
of SSD. Thus, several diagnostic exclusions
were put in place to limit the diversity of the
participants being reviewed and to reduce the
likelihood of multiple conditions influencing
reported outcome measures. The participants in
the articles were required to have an SSD. The
SSD could be classified as a residual or persistent speech error of unknown etiology or due to
a motor speech disorder such as CAS without
any comorbid excluded diagnoses (e.g., autism).
Article titles and abstracts were screened to
exclude studies considered to be outside of
the scope of the present review. Thus, all papers
related to participants diagnosed with the following disabilities were excluded: structural
anomalies (e.g., cleft palate), genetic syndromes
(e.g., Down’s syndrome), cerebral palsy, hearing
impairment, and autism. Screening removed
425 articles, leaving 52 to be assessed for
eligibility. A follow-up online search containing the names of the authors and intervention
types was conducted to ensure all relevant
articles were found.
Eligibility. Copies of articles were obtained and assessed against the final inclusion
criteria before being reviewed. These criteria
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were as follows: (1) peer-reviewed articles published between January 1980 and July 2018; (2)
written in English (to allow analysis by monolingual English-speaking authors); (3) reporting quantitative participant data outcomes
focused on articulation/phonology within treatment, during probe measures, or in spontaneous
speech; and (4) using visual biofeedback during
intervention. All visual biofeedback methods
were included, as were all levels of evidence,
except for systematic reviews, as they do not
contain individual participant data.30 During
the eligibility phase, researchers were not
blinded to article title or authors. Additionally,
the first and second authors of the current
article, both of who have published articles
under consideration, did not review their own
publications. Excluded articles were not analyzed further.
Final review. A final review of the remaining qualified articles was conducted to assess
individual cases within each study. Eligibility
decisions regarding inclusion of participant data
were made using a predetermined set of criteria:
(1) participant presented with no physiological
and physical limitations, (2) participant was
under 22 years of age with a speech sound error,
(3) the study demonstrated performance of
within-treatment practice trials, and (4) the
study provided individual participant data for
review. This selection yielded 29 articles from
which 138 participants were identified for analysis. Each study was assigned a level of evidence
according to published ASHA guidelines.30
Lastly, the following data were collected
and summarized for analysis: participant information (i.e., age, gender, speech and language
diagnosis), treatment information (i.e., biofeedback type, speech sound targets), study
design (i.e., case study, single-case experimental
design, level of evidence), session length
in minutes, dose, dose frequency, treatment
duration, and effect size (see Table 2).

Analysis
There were 29 visual biofeedback studies that
met the inclusion criteria for the present review.
All of the preestablished categories were independently coded by two members of the
research team (i.e., a trained graduate student
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Biofeedback Type, Gender, Age, Reported Diagnoses/Speech Targets Per Study

Biofeedback
type

Author(s)

46

Publication
date

Gender
M

F NR

Age
(mean; months)

Dx

Speech
targets

Dagenais et al

1994

–

2 –

103

RSE

Sibilants

Gibbon et al47
Gibbon et al48

1993
1990

–
1

1 –
– –

108
132

RSE
RSE

Stops
Sibilants

Hitchcock et al21

2017

2

3 –

93

RSE

Rhotics

Schmidt49
Adler-Bock et al3

2007
2007

5
1

2 –
– –

125
144

RSE
RSE

Multiple
Rhotics

Bressmann et al50

2016

1

–

–

108

RSE

Rhotics

Byun et al7
Cleland et al51

2014
2015

4
5

4 –
2 –

112
89

RSE
RSE

Rhotics
Multiple

Heng et al52

2016

1

1 –

54

RSE

Velars

Hitchcock and Byun53
Lee et al54

2015
2015

–
1

1 –
– –

134
156

RSE
RSE

Rhotics
Rhotics

Modha et al55

2008

1

–

–

156

RSE

Rhotics

Preston et al6
Preston et al8

2013
2014

3
6

– –
2 –

156
149

CAS Multiple
RSE Multiple

Preston et al41

2015

3

–

–

132

CAS Rhotics

Preston et al27
Preston and Leece26

2016
2017

1
2

– –
2 –

158
119

CAS Rhotics
RSE Rhotics

Preston et al56

2017

8

4 –

144

RSE

Preston et al57
Preston et al58

2017
2018

7
4 –
12 – –

119
136

CAS Rhotics
RSE Rhotics

Shawker and Sonies59

1985

–

1 –

108

RSE

Rhotics

Visual

Sjolie et al60
McAllister Byun61

2016
2017

–
5

– 4
2 –

102
147

RSE
RSE

Rhotics
Rhotics

acoustic

McAllister Byun et al18

2016

6

EPG

Ultrasound

(StaRt App)

Rhotics

3 –

116

RSE

Rhotics

2012
Byun and Hitchcock5
McAllister Byun and Campbell9 2016

10 1 –
7
4 –

108
135

RSE
RSE

Rhotics
Rhotics

Shuster et al1

1995

1

1 –

144

RSE

Rhotics

McAllister Byun et al62

2017

–

1 –

156

RSE

Rhotics

Abbreviations: CAS, childhood apraxia of speech; multiple, multiple treatment targets per study; RSE, residual
speech error.

or an author). Lastly, the authors met to review
the coding of the 29 studies and resolve any
discrepancies to finalize the dataset.
Treatment intensity measures. As stated
previously, a primary goal of the present research
was to explore the nature of the relationship
between treatment intensity and the efficacy of
visual biofeedback intervention for individuals
with SSD. To investigate these variables, the CII
was selected as a composite measure of treatment
intensity. The CII, as described earlier, is the
product of dose  dose frequency  total intervention duration.24 Eighteen of the 29 studies
adequately reported the variables of dose, dose

frequency, and total intervention duration,
making it possible to calculate a CII score for
114 participants out of a total of 138 participants.a A summary of the calculated CII values
per study is reported in Table 3.
Treatment effect measures. Initially, an
improvement rate difference (IRD), defined as
the improvement rate of the baseline phase
subtracted from the improvement rate of the
a

Five of the reviewed studies reported an average dose value
and one reported an average CII value. Due to the
preliminary nature and limited accessible data for the
current review, we did not exclude these studies.
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Table 3

2019

Biofeedback Type, Research Design, LOE, Effect Size, MLD, CII Per Study

Biofeedback Author(s)
type
EPG

Publication Research
date
design

LOE Reported
Calculated
Effect size MLD CII

1994

Cseries

III

N

N

2,300a

Gibbon et al

1993

CS

III

N

N

–

Gibbon et al48
Hitchcock et al21

1990
2017

CS
SCED

III
IIb

N
N

N
N

–
840

Schmidt49

2007

Cseries

III

N

N

–

Adler-Bock et al3
Bressmann et al50

2007
2016

CS
RCT

III
Ib

N
N

N
N

–
–

Byun et al7

2014

SCED

IIb

Y

Y

840

Cleland et al51
Heng et al52

2015
2016

Cseries
SCED

III
IIb

N
N

Y
N

–
–

Hitchcock and Byun53

2015

CS

III

Y

Y

1,020

Lee et al54
Modha et al55

2015
2008

CS
CS

III
III

N
N

N
N

–
–

Preston et al6

2013

SCED

IIb

Y

Y

4,104

Preston et al8
Preston et al41

2014
2015

SCED
IIb
G w/in MB IIb

Y
N

Y
Y

2,940
1,988

Preston et al27

2016

Cseries

III

Y

Y

–

Preston and Leece26
Preston et al56

2017
2017

Cseries
SCED

III
IIb

Y
Y

Y
Y

5,117a
4,115

Preston et al57

2017

SCED

IIb

Y

Y

1,144a

58

Preston et al
Shawker and Sonies59

2018
1985

SCED
CS

IIb
III

Y
N

Y
N

2,592
–

Sjolie et al60

2016

SCED

IIb

Y

N

3,010

McAllister Byun61
McAllister Byun et al18

2017
2016

SCED
SCED

IIb
IIb

Y
Y

Y
N

1,200
1,920

Byun and Hitchcock5

2012

Dagenais et al46
47

Ultrasound

Visual
acoustic

(StaRt App)

SCED

IIb

N

N

2,400

McAllister Byun and Campbell9 2016
1995
Shuster et al1

SCED
Cseries

IIb
III

Y
N

Y
N

1,200
1,600a

McAllister Byun et al62

CS

III

N

Y

1,200

2017

Abbreviations: CII, cumulative intervention index; CS, case studies; Cseries, case series; LOE, level of evidence;
MLD, mean level difference; SCED, single-case experimental designs.
a
Average CII score.

post-baseline phase, was selected to assess
treatment outcomes across studies because an
IRD is sensitive to changes in treatment masked by other standardized effect sizes. Additionally, it is easy to calculate, relatively
straightforward to interpret, and has been previously used to analyze treatment effects in
single-case research pertaining to SSDs.31
Unfortunately, the IRD was ultimately abandoned, as the majority of studies did not report
enough evidence to calculate this type of effect
size. A standardized effect size by participant was
also ruled out because it can be difficult to
interpret as an independent measure of treat-

ment outcomes and cannot be calculated when
there is zero variance in the measured data
periods.b21,32 Moreover, effect size has not
been consistently reported in the biofeedback
literature. Due to these concerns, use of the
mean level difference was judged to be the best
available independent indicator of a change in
participants’ speech behavior. The mean level
difference is defined as the raw difference
b

Zero variance can occur in the baseline period of a treatment
program where target sound production accuracy is zero or a
maintenance period where mastery of a target sound is
complete.
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between the mean percentage of items rated
correct in maintenance and baseline intervals.
For the purposes of this paper, when multiple
targets were reported, the target with the largest
accuracy gain was selected for inclusion to
identify instances where the treatment intensity
was paired with a change in behavior (i.e.,
acquisition or improvement in target speech
sound). We recognize that there are clear
limitations of using the proposed measure of
treatment efficacy, yet significant gaps in the
reported data resulted in few options for estimating biofeedback treatment gains across studies. We revisit this issue in the discussion.

RESULTS
The 29 studies that met inclusion criteria
consisted of 1 level Ib study, 14 level IIb
(single-case experimental designs or SCEDs),
and 14 level III (case series/case studies). There
was a shift toward higher quality single-case
studies over time as well as an increase in the
number of studies using visual biofeedback,
with all six studies prior to 2010 representing
only level III evidence and a preponderance of
level IIb evidence between 2011 and 2018 (22
studies). The one level Ib study was from 2016.
Participant profiles included 120 RSE
(mean age: 10; 7) and 18 CAS (mean age: 10;
10) participants. A higher proportion of male
(n ¼ 93) versus female representation (n ¼ 41)
was observed in the gender distribution data.
This finding is in keeping with previous literature indicating a greater prevalence of RSE
among males than in females.33–35 A summary
of the data by study with relevant participant
characteristics can be found in Table 2.
After coding each of the categories defined
previously, we derived a measure of treatment
intensity, or CII score, for 114 of 138 participants. Participants were excluded from this
subgroup due to missing data in one or more of
the composite CII categories. Mean level difference scores were reported for 86 of the
participants with a calculated CII score. Unreported baseline or maintenance scores resulted
in the smaller sample size for the combined CII
and mean level difference subset. Table 3 offers
a summary of the review data for the CII and
mean level difference scores by research study.

Correlations
Pearson’s product–moment correlation coefficients were computed to assess the relationship
between the measures of treatment intensity and
treatment effects. Correlation coefficients were
calculated for CII and mean level difference.
Correlation coefficients were also calculated for
the component variables of the CII score (dose,
dose frequency, treatment duration) and mean
level difference.
The strongest correlations observed between
the mean level difference scores and predictor
variables were CII, dose, and duration. Significant
positive correlations between mean level difference and CII (r ¼ 0.227, n ¼ 86, p ¼ 0.035) as
well as mean level difference and dose (r ¼ 0.223,
n ¼ 86, p ¼ 0.039) indicated weak but statistically significant associations between the effects of
treatment and treatment intensity, specifically
related to the individual factor of dose (teaching
trials per session). Mean level difference score and
duration were significantly (negatively) correlated
but were small in magnitude (r ¼ 0.226,
n ¼ 86, p ¼ 0.037). The correlation between
mean level difference and frequency was not
significant (r ¼ 0.164, n ¼ 86, p ¼ 0.131).
The preliminary nature of the present data precludes further analysis.

DISCUSSION
Overview
The aim of this study was to explore the nature
of the relationship between treatment intensity
and efficacy of visual biofeedback treatment by
conducting a review of the existing biofeedback
literature. Several decades of research have
documented the use of biofeedback for evaluation and treatment of speech error patterns
resulting from a variety of diagnoses including
articulation and phonological disorders, cleft
palate, apraxia, dysarthria, hearing impairment,
Down’s syndrome, and cerebral palsy, among
others.18,36–41 The heterogeneous nature of
these diagnoses was considered too broad to
assess as one body of research; therefore, the
present review was limited to research studies
involving visual biofeedback for treatment of
speech sound errors of unknown or motorbased etiology. Twenty-nine studies, covering
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three major types of biofeedback, qualified for
in-depth review.

Summary of Findings
The findings from this preliminary review of
biofeedback intervention revealed that the CII
and one of the component parts, dose, showed
small but significant positive relationships with
treatment efficacy as measured by mean level
difference scores. This finding suggests that
changes in speech behaviors are influenced by
treatment intensity or dosage, with higher dose
values providing additional opportunities for
practice and, thus, improvement. This is consistent with past research indicating that the
motor component of speech production responds well to multiple repetitions of a task to
improve performance.42
Additionally, the correlation results indicated a negative relationship between mean level
difference and duration suggesting that the parameters of dose, dose frequency, and duration may
be manipulated quite broadly to facilitate changes
in speech behaviors. More clearly, it is possible
that a short duration of treatment with a clustered
session frequency distribution (i.e., 3 weeks  4
sessions per week) might be preferable to a longer
duration of treatment with sessions widely distributed (i.e., 12 weeks  1 session per week).
Taken in context with the reviewed literature,
this finding raises the possibility that a short study
duration may have an equal or greater impact on
treatment progress assuming other parameters
(i.e., dose, dose frequency) are increased accordingly to compensate for shorter duration and
maintain overall treatment intensity. In the study
conducted by Preston and Leece,26 all four
participants demonstrated measurable and statistically significant gains when treated twice per
day for a period of 1 week at a high dose (M
dose ¼ 366; SD ¼ 165). Adjusting the variables
of duration and frequency alters the schedule of
treatment, offering different practice schedules,
such as mass versus distributed practice of a target
speech task. According to Maas et al,10 the
optimal practice schedule may depend on the
nature of the motor speech disorder. Manipulating the variables of intensity to facilitate best
outcomes recognizes that an effective intensity
level for one type of treatment may not be equally
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as effective for another type of treatment.24 Thus,
the need for further investigation of intensity
measures is justified by the presence of both
responders and nonresponders reported across
the analyzed studies of different treatment intensities and the knowledge that optimal intensity
may vary with disorder type. Additionally, the
current review demonstrates that the parameters
of treatment intensity and outcomes are not
systematically reported in such a way that makes
it easy to draw firm conclusions about relationships between them.

Limitations
Levels of evidence. The studies examined were
primarily divided between level III evidence and
level IIb evidence, although a promising trend
toward more rigorous research designs was
observed. This upward shift seems to coincide
with the development of ASHA guidelines33
recommending the use of evidence-based practice (EBP) in clinical treatment. Even though
the published literature does not yet include
large-scale, peer-reviewed studies using visual
biofeedback for treatment of SSDs, several of
the reviewed studies employed sound methodological practices (e.g., single-case experimental designs). It should be noted, however, that
this review included a disproportionate number
of studies from a small pool of authors, which
may reduce the overall strength of our analysis.
Although visual biofeedback is currently a
developing research area, we expect that future
studies will demonstrate increasing quality,
more rigorous study designs, and a larger set
of researchers.
Lack of consistency in reporting across
studies. The present review revealed a surprising lack of unity when reporting parameters
of treatment intensity and outcomes. Approximately one-third of the reviewed studies were
missing at least one of the defined CII components (dose, dose frequency, and duration),
complicating the data coding. In addition,
several authors reported session length in lieu
of the number of teaching episodes per session.
Adopting a standard set of parameters for
reporting intensity, such as the CII, would
move the state of the literature forward in a
clinically meaningful way.
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The parameter most frequently unreported
was dose, identified in the current study as being
a factor of interest when studying treatment
intensity. The current findings provide preliminary evidence that this variable is potentially
meaningful for overall efficacy, but more work
needs to be done to evaluate the strength of this
relationship. Research to explore the proposed
explanation for the negative durational relationship and the lack of a correlation between
frequency and efficacy would also be beneficial.
Measures of treatment efficacy were also
found to be inconsistently reported across studies. Reporting on treatment outcomes ranged
from inclusion of (1) a posttreatment measure at
the spontaneous word level, (2) baseline and
posttreatment measures of spontaneous speech,
(3) a baseline and posttreatment untreated
probe score, (4) mean level difference scores
for untreated probes, (5) mean-level difference
and effect sizes of untreated probes, and (6)
mean level differences for treated and untreated
probes. It should be acknowledged that the
previously identified shift toward studies with
higher levels of evidence should resolve some of
these inconsistencies assuming certain minimum standards of reporting outcomes are
established/met in future research.
Also noteworthy is the confounding
variable of multiple treatment targets in a
treatment session. The current study reported
only the gains of the most improved treatment
target per participant. This strategy was based
on the rationale that if gains were observed, it
would be most meaningful to identify the
treatment intensity of targets acquired rather
than the treatment intensity of targets not
acquired. However, in some instances, reported
measures of intensity were not specific to a
target, making it impossible to determine
dose per target. The importance of reporting
target-specific intensity measures cannot be
understated if the ultimate goal is to use such
findings to guide clinical practice.

Future Recommendations
The current data included multiple biofeedback
types, such that ultrasound, visual-acoustic (LPC
and spectrographic), and EPG measures were
treated as one biofeedback method. The diversity

of these intervention types is significant considering that ultrasound and EPG offer the ability to
view articulator movements concealed within the
oral/pharyngeal cavity, while visual acoustic displays show a graphic representation of an acoustic
speech signal. Presently, it is not possible to
determine if the intensity/efficacy relationship
identified here is consistent across all methods or
more strongly related to a particular type of
biofeedback and/or speech sound error type.
For example, the least optimal biofeedback
type for rhotic errors may be EPG, which shows
information about lateral bracing of the tongue
but yields little information about other more
salient features of rhotic articulation.21 Given the
preliminary nature of this review and the disproportionate number of ultrasound participants
compared with visual-acoustic and EPG, identification of an interaction suggesting a preferred
biofeedback type was considered premature.
The calculation of treatment outcomes presented several challenges in the current investigation. Significant gaps and inconsistencies in
the reported data resulted in few options for
estimating the efficacy of biofeedback treatment
across studies. As a result, we chose to use a mean
level difference score for reasons previously cited.
However, it is possible that the mean level
difference accuracy score does not adequately
reflect the degree of change in participant behavior. Assessments conducted only in the pre- and
posttreatment periods and, more importantly,
only on untreated targets could mask the early
acquisition phase of a speech sound. Several
researchers have indicated that the addition of
the visual modality in biofeedback seems to be
most effective for the learner during this early
acquisition period,2,20 which suggests that tracking accuracy improvement rates for withintreatment trials is particularly relevant to biofeedback research. In future investigations of
treatment intensity, a more reliable measure of
a change in participant speech behavior, such as
an IRD, needs to be clearly established and
validated as a measure of treatment efficacy.
Finally, the ultimate goal of an intervention
program is generalization of the target speech
behavior to naturalistic settings. This type of
improvement is observed when a treated target
is mastered and spontaneously produced in novel
utterances and conversational speech. In the
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present research, generalization to spontaneous
speech was evaluated by 31% of the studies, and
all of these studies were found to be level III
evidence, primarily case studies and case series.
Although a relatively high percentage of these
participants were reported to achieve generalization to spontaneous speech, the strength of the
conclusions that can be drawn from the results is
intrinsically limited by the use of a single-subject
case study or case series study design. The remaining 69% of the studies reported posttherapy
probe measures in structured contexts (14 level
IIb, 4 level III, and 1 level Ib studies). Regardless
of the level of evidence, using probe measures as
the only method of assessing generalization does
not differentiate between gains observed in elicited versus spontaneous contexts, a fact which
merits consideration in future research.

Clinical Relevance
A primary goal of both the researcher and
clinician is to identify and implement best
practice procedures. To identify best practice
for a population such as SSD, it is necessary to
assess proposed treatment variables in an organized and systematic fashion. However, it is a
reality that many speech–language pathologists
encounter overwhelming caseloads and have
little time to review and compare evidence for
emerging treatment programs. Given limited
time and resources, identifying, implementing,
and tracking measures of treatment (e.g., dosage,
practice conditions) supported by EBP can be
challenging for any dedicated clinician; yet, it is a
vital part of the clinical decision-making process.
A composite score such as the CII offers
clinicians the ability to effectively quantify an
overall treatment intensity as well as the individual components of dose, dose frequency, and
treatment duration. Using the CII, clinicians
can directly investigate its effect on treatment
outcomes, a concept that has previously been
suggested as a necessary direction for speech
and language research.24 In the present study,
we reviewed biofeedback treatment both as a
preliminary review of the literature summarizing the existing evidence for biofeedback intervention (see previous review) and as an example
of how clinicians can use CII in the clinical
decision-making process.
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Typically, clinicians select an appropriate
intervention based on clinical education about
the efficacy of the treatment for the communication disorder of the individual while simultaneously considering other variables that may
facilitate or impede treatment outcomes.43 Of
these variables, service delivery, and more specifically treatment intensity, is often defined as the
frequency and duration of treatment. The additional consideration of dose, a less commonly
reported factor of treatment intensity, may help
clinicians explain variations in client outcomes for
a given treatment program administered with
different intensities. Allen,12 investigating treatment intensity and a multiple oppositions
approach for SSD, reported that increasing frequency of intervention yielded greater improvements for participants when the overall CII
remained the same. As noted previously, Preston
and colleagues26 significantly altered variables of
treatment intensity compared with other biofeedback studies and reported positive treatment
outcomes. These findings align with the premise
that increasing frequency of intervention associated with high overall intensity will lead to improvement of a desired behavior.44 However, Baker
and McLeod45 reported that many SSD studies
document measures of dose frequency and treatment duration; yet, very few reported dose, a
finding also noted in the current study, and one
that makes it difficult for clinicians to replicate
treatment programs from studies with positive
outcomes. Our preliminary findings suggest that
planning, implementing, tracking, and adjusting
dose, as well as frequency and duration, may help
improve treatment efficacy.
Our findings also highlight the need to
establish a unified measure of treatment efficacy. We recognize that several past researchers
have used effect size as a measure of treatment
outcomes. However, an effect size cannot be
calculated when there is no change in a measured period of time (i.e., maintenance period
where mastery of a target sound is complete),
making it difficult to use as the primary measure
of treatment outcomes, nor is it easily calculated
by clinicians. We used the MLD score to
measure treatment outcomes, a measure which
is easily calculated but does not calculate within-treatment accuracy gains. Other measures,
such as an IRD, seem promising for future use
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CONCLUSIONS
It is clear that we are at the forefront of a rapidly
developing area of research in SSD, one that
extends well beyond the subset of data evaluated
in the current work. As interest in visual
biofeedback grows and lowering equipment
costs support increased access to practicing
clinicians, clear guidelines for treatment are
imperative. The present review underscores
the need for more systematic language and
reporting methods when exploring the relationship between biofeedback intervention for
SSDs and factors of treatment intensity.
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